Comparison of mechanisms by which apoA-I in α- and pre-β-HDL mediates cell cholesterol efflux

被引：0
|
作者：
Gillotte, KL [1 ]
Lund-Katz, S [1 ]
Rothblat, GH [1 ]
Phillips, MC [1 ]
机构：
[1] Allegheny Univ Hlth Sci, Philadelphia, PA 19102 USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2378
引用
收藏
页码：A1263 / A1263
页数：1
相关论文
共 50 条
  • [41] Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
    Hosoai, H
    Webb, NR
    Glick, JM
    Tietge, UJF
    Purdom, MS
    de Beer, FC
    Rader, DJ
    JOURNAL OF LIPID RESEARCH, 1999, 40 (04) : 648 - 653
  • [42] AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux
    Zhang, Tao
    Wang, Qilong
    Wang, Yeqi
    Wang, Junping
    Su, Yongping
    Wang, Fengchao
    Wang, Guixue
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [43] AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux
    Tao Zhang
    Qilong Wang
    Yeqi Wang
    Junping Wang
    Yongping Su
    Fengchao Wang
    Guixue Wang
    Journal of Translational Medicine, 17
  • [44] ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity
    Liz, Marcia Almeida
    Gomes, Claudio M.
    Saraiva, Maria Joao
    Sousa, Monica Mendes
    JOURNAL OF LIPID RESEARCH, 2007, 48 (11) : 2385 - 2395
  • [45] ABCA1 expression in Tangier fibroblasts restores ApoA-I mediated cholesterol efflux
    Neufeld, EB
    Stonik, JA
    Demosky, SJ
    Knapper, C
    Remaley, AT
    Santamarina-Fojo, S
    Brewer, HB
    CIRCULATION, 2003, 108 (17) : 72 - 72
  • [46] A NOVEL APOA-I MIMETICS, FAMP CONSTRUCTS PRE-BETA HDL IN VITRO AND IN VIVO
    Uehara, Y.
    Oniki, K.
    Tanigawa, H.
    Abe, S.
    Ando, S.
    Yahiro, E.
    Miura, S. -I.
    Saku, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 40 - 40
  • [47] IDENTIFICATION OF A SEQUENCE OF APOLIPOPROTEIN-A-I ASSOCIATED WITH THE EFFLUX INTRACELLULAR CHOLESTEROL TO HUMAN APOA-I CONTAINING PARTICLES
    SVIRIDOV, D
    PYLE, L
    FIDGE, N
    CIRCULATION, 1995, 92 (08) : 3310 - 3310
  • [48] A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity
    Seckler, Henrique dos Santos
    Fornelli, Luca
    Mutharasan, R. Kannan
    Thaxton, C. Shad
    Fellers, Ryan
    Daviglus, Martha
    Sniderman, Allan
    Rader, Daniel
    Kelleher, Neil L.
    Lloyd-Jones, Donald M.
    Compton, Philip D.
    Wilkins, John T.
    JOURNAL OF PROTEOME RESEARCH, 2018, 17 (06) : 2156 - 2164
  • [49] Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
    S. S. Soedamah-Muthu
    H. M. Colhoun
    M.-R. Taskinen
    B. Idzior-Walus
    J. H. Fuller
    Diabetologia, 2000, 43 : 1353 - 1359
  • [50] Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate
    Taskinen, Marja-Riitta
    Sullivan, David R.
    Ehnholm, Christian
    Whiting, Malcolm
    Zannino, Diana
    Simes, R. John
    Keech, Anthony C.
    Barter, Philip J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (06) : 950 - U436
12345